Clinical Trials in Miami

Showing 5481-5500 of 11,431 trials

Phase I/II Safety, Dose Finding & Antiviral Activity of RD-X19 in Mild/Moderate Outpatient COVID-19

NCT04662671

This randomized, Phase I/II feasibility study will evaluate the safety and efficacy of the RD-X19 device in SARS-CoV-2 infected individuals with uncomplicated COVID-19.

COVID19

EmitBio Inc.31 participantsStarted Nov 2020

Miami, Florida, United States • College Station, Texas, United States

TERMINATEDPhase 2< 1 mile

Antithrombin III in Infectious Disease Caused by COVID-19

NCT04899232

The purpose of this research study is to see if participants who have SARS-CoV-2 and low levels of AT3 in the blood will benefit by being given AT3.

Antithrombin III DeficiencyCovid19

Enrique Ginzburg52 participantsStarted Jul 2021

Miami, Florida, United States

COMPLETEDPhase 2< 1 mile

The Safety, Efficacy and Pharmacokinetics of ARQ-151 Cream in Subjects With Chronic Plaque Psoriasis

NCT03638258

This is a parallel group, double blind, vehicle-controlled study in which roflumilast (ARQ-151) cream 0.3%, roflumilast cream 0.15%, or vehicle cream is applied once daily (QD) for 84 days to subjects with chronic plaque psoriasis involving between 2 and 20% body surface area.

Plaque Psoriasis

Arcutis Biotherapeutics, Inc.331 participantsStarted Sep 2018

Beverly Hills, California, United States • Northridge, California, United States • San Diego, California, United States +27 more locations

Phase I/II Safety, Dose Finding & Antiviral Activity of RD-X19 in Mild/Moderate Outpatient COVID-19

Antithrombin III in Infectious Disease Caused by COVID-19

The Safety, Efficacy and Pharmacokinetics of ARQ-151 Cream in Subjects With Chronic Plaque Psoriasis

Find Trials by Condition in Miami

Safety and Efficacy Study of DUR-928 Topical Solution in Subjects With Plaque Psoriasis

Long-Term Safety of ARQ-151 Cream in Adult Subjects With Chronic Plaque Psoriasis

A Prospective Study of Early Mechanical Stabilization and Bleeding in Disruption of the Pelvic Ring

A Study of Mirikizumab (LY3074828) in Participants With Active Crohn's Disease

Safety and Efficacy of AbobotulinumtoxinA for the Treatment of Platysmal Bands

Phase 2 Study on Effects of Obeticholic Acid (OCA) on Lipoprotein Metabolism in Participants With Primary Biliary Cirrhosis

A Comparison Study of LY2140023 and Aripiprazole in Schizophrenia Patients

Safety and Efficacy of AbobotulinumtoxinA for the Treatment of Glabellar Lines

Efficacy and Safety of a New Dilution and Injection Volume of AbobotulinumtoxinA for the Treatment of Glabellar Lines

To Evaluate the Safety, and Pharmacokinetics of Parscaclisib in Participants With Normal Hepatic Function and Hepatic Impairment.

A Validation Study of the NightOwl Home Sleep Apnea Test

Safety and Efficacy Study of Botulinum Toxin for the Treatment of Glabellar Frown Lines

Open-Label Extension and Safety Study of Talazoparib

Post Approval Study: NOVATION Ceramic Articulation Hip System

A Mind-Body Medicine Curriculum for Peer Counselors

Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Miricorilant in Participants With Presumed Nonalcoholic Steatohepatitis (NASH)

Sapanisertib or Pazopanib Hydrochloride in Treating Patients With Locally Advanced or Metastatic Sarcoma